DOI:
10.1055/s-00000041
Neuropediatrics
LinksClose Window
References
Kishnani PS, Corzo D, Nicolino M. et al.
Recombinant human acid α-glucosidase. Major clinical benefits in infantile-onset Pompe disease.
Neurology 2007; 68: 1-11
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.